Circulating mediators such as interleukin (IL)-6, tumor necrosis factor-alpha (TNF-alpha), C-reactive protein (CRP) and adhesion molecules secondary to rheumatic inflammatory processes contribute to all stages of atherosclerosis: from endothelial dysfunction to atheroma formation, plaque instability and thrombus development.2 The gene discussed is CRP; the disease is atherosclerosis.